Phibro Animal Health Corporation (PAHC)
Automate Your Wheel Strategy on PAHC
With Tiblio's Option Bot, you can configure your own wheel strategy including PAHC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol PAHC
- Rev/Share 29.3996
- Book/Share 6.5677
- PB 4.2648
- Debt/Equity 2.8949
- CurrentRatio 2.9121
- ROIC 0.0522
- MktCap 1135346360.0
- FreeCF/Share 1.2113
- PFCF 23.1429
- PE 35.6821
- Debt/Assets 0.5846
- DivYield 0.0171
- ROE 0.1237
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 2
- DCF Score 1
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | PAHC | JP Morgan | Neutral | Overweight | -- | $35 | July 7, 2025 |
| Upgrade | PAHC | BNP Paribas Exane | Underperform | Neutral | -- | $24 | June 16, 2025 |
| Initiation | PAHC | JP Morgan | -- | Neutral | -- | $22 | Sept. 10, 2024 |
News
3 Reasons Growth Investors Will Love Phibro (PAHC)
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Published: May 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Phibro Q3 Earnings Top Estimates, Stock Up, 2025 EPS Outlook Raised
Published: May 08, 2025 by: Zacks Investment Research
Sentiment: Positive
PAHC's third-quarter fiscal 2025 results reflect the strength of the Animal Health segment.
Read More
Compared to Estimates, Phibro (PAHC) Q3 Earnings: A Look at Key Metrics
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Phibro (PAHC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates
Published: May 07, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro Animal Health (PAHC) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.31 per share a year ago.
Read More
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Published: April 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
PAHC or BSX: Which Is the Better Value Stock Right Now?
Published: April 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Published: April 16, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -13.52% in 4 Weeks
Published: April 11, 2025 by: Zacks Investment Research
Sentiment: Neutral
The heavy selling pressure might have exhausted for Phibro (PAHC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Read More
Here is Why Growth Investors Should Buy Phibro (PAHC) Now
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) could produce exceptional returns because of its solid growth attributes.
Read More
Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence
Published: April 09, 2025 by: Zacks Investment Research
Sentiment: Negative
In the present market turbulence, investors may want to consider discounted stocks, such as FMS, PAHC and COR.
Read More
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term
Published: April 08, 2025 by: Zacks Investment Research
Sentiment: Positive
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Read More
PAHC vs. BSX: Which Stock Is the Better Value Option?
Published: March 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
Is Phibro Animal Health (PAHC) Stock Undervalued Right Now?
Published: March 31, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
3 Undervalued MedTech Stocks to Buy for 2025 Gains Amid S&P 500 Rally
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Three discounted MedTech stocks to gain from the market rebound are PAHC, FMS and INMD.
Read More
Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Read More
PAHC vs. BSX: Which Stock Should Value Investors Buy Now?
Published: March 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Is Phibro Animal Health (PAHC) a Great Value Stock Right Now?
Published: March 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Phibro Animal Health Stock Up 87.5% in a Year: What's Driving the Rise?
Published: March 10, 2025 by: Zacks Investment Research
Sentiment: Neutral
PAHC stays on investors' radar due to its Animal Health business and potential in emerging markets.
Read More
Why Is Phibro (PAHC) Down 5.2% Since Last Earnings Report?
Published: March 07, 2025 by: Zacks Investment Research
Sentiment: Negative
Phibro (PAHC) reported earnings 30 days ago. What's next for the stock?
Read More
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Is PAHC Stock a Smart Addition to Your Portfolio Right Now?
Published: February 28, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro's robust performance in the Animal Health business and prospects in the emerging markets are highly encouraging.
Read More
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC)
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market.
Read More
PAHC or SYK: Which Is the Better Value Stock Right Now?
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now?
Read More
Bears are Losing Control Over Phibro (PAHC), Here's Why It's a 'Buy' Now
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Negative
Phibro (PAHC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Read More
Should Value Investors Buy Phibro Animal Health (PAHC) Stock?
Published: February 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Read More
Phibro Animal Health Corporation to Participate at Bank of America 2025 Virtual Animal Health Summit
Published: February 20, 2025 by: Business Wire
Sentiment: Neutral
TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2025 Virtual Animal Health Summit. Chief Financial Officer, Glenn David will address financial analysts and investors on Thursday, February 27, 2025, at 10:50 AM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com. A replay of the session will be available and arch.
Read More
4 PEG-Based Value Stocks to Shield Your Portfolio From Trade War
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
Here are four PEG-driven GARP stocks, GM, EXPE, PAHC and PPC, which qualify our screening criteria.
Read More
Best Momentum Stocks to Buy for February 14th
Published: February 14, 2025 by: Zacks Investment Research
Sentiment: Positive
FINW, SFTBY and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 14, 2025.
Read More
About Phibro Animal Health Corporation (PAHC)
- IPO Date 2014-04-11
- Website https://www.pahc.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Jack Clifford Bendheim
- Employees 1940